FdaApplication
NDA 202381
Identifiers
- fda_app_no: NDA202381
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABS |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABACAVIR SULFATE; LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | 60MG;30MG | TABLET;ORAL |
1 product